Literature DB >> 32761451

Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs.

Bo Yu1, Chenze Li1, Peng Chen1, Jia Li2, Hualiang Jiang3,4, Dao-Wen Wang5.   

Abstract

Entities:  

Year:  2020        PMID： 32761451      PMCID： PMC7406960          DOI： 10.1007/s11427-020-1782-1

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
  7 in total

Review 1.  Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?

Authors:  Lucie Pothen; Halil Yildiz; Mathilde Mbouck Samnick; Jean Cyr Yombi
Journal:  Clin Rheumatol       Date:  2021-01-15       Impact factor: 3.650

2.  Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo.

Authors:  Haoran Peng; Cuiling Ding; Liangliang Jiang; Wanda Tang; Yan Liu; Lanjuan Zhao; Zhigang Yi; Hao Ren; Chong Li; Yanhua He; Xu Zheng; Hailin Tang; Zhihui Chen; Zhongtian Qi; Ping Zhao
Journal:  Sci China Life Sci       Date:  2021-12-24       Impact factor: 10.372

3.  Cardiovascular Involvement in Patients with 2019 Novel Coronavirus Disease.

Authors:  Chenze Li; Dao Wen Wang; Chunxia Zhao
Journal:  J Transl Int Med       Date:  2021-09-28

4.  Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study.

Authors:  Toussaint Rouamba; Houreratou Barry; Esperance Ouédraogo; Marc Christian Tahita; Nobila Valentin Yaméogo; Armel Poda; Arnaud Eric Diendéré; Abdoul-Salam Ouedraogo; Innocent Valea; Amariane M Koné; Cherileila Thiombiano; Isidore Traoré; Zekiba Tarnagda; Serge A Sawadogo; Zakaria Gansané; Yibar Kambiré; Idrissa Sanou; Fatou Barro-Traoré; Maxime K Drabo; Halidou Tinto
Journal:  Ther Clin Risk Manag       Date:  2021-11-15       Impact factor: 2.423

5.  Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.

Authors:  Toussaint Rouamba; Esperance Ouédraogo; Houreratou Barry; Nobila Valentin Yaméogo; Apoline Sondo; Rainatou Boly; Jacques Zoungrana; Abdoul Risgou Ouédraogo; Marc Christian Tahita; Armel Poda; Arnaud Eric Diendéré; Abdoul-Salam Ouedraogo; Innocent Valea; Isidore Traoré; Zekiba Tarnagda; Maxime K Drabo; Halidou Tinto
Journal:  Int J Infect Dis       Date:  2022-02-26       Impact factor: 12.074

6.  Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.

Authors:  Bhagteshwar Singh; Hannah Ryan; Tamara Kredo; Marty Chaplin; Tom Fletcher
Journal:  Cochrane Database Syst Rev       Date:  2021-02-12

Review 7.  Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review.

Authors:  C Prodromos; T Rumschlag
Journal:  New Microbes New Infect       Date:  2020-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.